MELEA MULLICAN: Open Payments
NPI 1114557030 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 13 payments from 7 companies in 2025. Trend: 2023 $139 · 2024 $215 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| Janssen Biotech, Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $42 |
| ARRAY BIOPHARMA INC | 2 | $35 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Aveo Pharmaceuticals, Inc. | 1 | $17 |
Products named: KISQALI, BRAFTOVI, TECVAYLI, ELAHERE, QINLOCK, PADCEV, ERLEADA, SCEMBLIX.
Industry payments across AL — which companies pay providers there.
